Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
Uppsala University
Upsala, SueciaPublicaciones en colaboración con investigadores/as de Uppsala University (10)
2023
-
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)
Leukemia
-
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Leukemia, Vol. 37, Núm. 2, pp. 339-347
2022
-
In vitro anticancer activity and mechanism of action of an aziridinyl galactopyranoside
Biomedicines, Vol. 10, Núm. 1
2020
-
The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome
Nature Cancer, Vol. 1, Núm. 11, pp. 1066-1081
2019
-
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
Haematologica, Vol. 104, Núm. 2, pp. 360-369
2016
-
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors
Haematologica, Vol. 101, Núm. 8, pp. 959-967
-
Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
Leukemia, Vol. 30, Núm. 11, pp. 2179-2186
2015
-
A transgenic Prox1-Cre-tdTomato reporter mouse for lymphatic vessel research
PLoS ONE, Vol. 10, Núm. 4
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12
-
Recurrent mutations refine prognosis in chronic lymphocytic leukemia
Leukemia, Vol. 29, Núm. 2, pp. 329-336